Shields Health Solutions Partners with Major Academic Medical Center to Expand Specialty Pharmacy Services
STOUGHTON, Mass. (May 13, 2025)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country announced it has partnered with Duke Health, a leading academic health system in North…
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy
According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…
Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions
Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…
Shields Outcomes 2024 Report
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy
This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.
Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation
This poster aims to establish goals for a dashboard displaying medication adherence by disease state and PDC thresholds through a comprehensive literature review, validating the existing targets.
Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients
This poster explores the impact of a Health System Specialty Pharmacy care model paired with a pharmacist-led CDTM program on CF patient outcomes.